CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 137 filers reported holding CHINA BIOLOGIC PRODS INC in Q1 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $350,000 | -6.9% | 3,500 | 0.0% | 0.10% | -65.0% |
Q4 2016 | $376,000 | -77.6% | 3,500 | -74.1% | 0.30% | -54.3% |
Q3 2016 | $1,680,000 | -22.9% | 13,500 | -11.8% | 0.66% | +101.2% |
Q4 2015 | $2,180,000 | +21.4% | 15,300 | -23.5% | 0.33% | -73.5% |
Q3 2015 | $1,796,000 | -46.5% | 20,000 | -31.4% | 1.23% | +26.0% |
Q2 2015 | $3,358,000 | -12.1% | 29,160 | -27.1% | 0.98% | -30.2% |
Q1 2015 | $3,820,000 | +42.1% | 40,000 | 0.0% | 1.40% | +11.0% |
Q4 2014 | $2,689,000 | +42.4% | 40,000 | +14.3% | 1.26% | +34.0% |
Q3 2014 | $1,889,000 | +21.4% | 35,000 | 0.0% | 0.94% | -12.2% |
Q2 2014 | $1,556,000 | – | 35,000 | – | 1.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPQ Asia Capital Ltd | 228,777 | $24,597,000 | 12.30% |
Ariose Capital Management Ltd | 238,841 | $25,680,000 | 8.36% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 8,400 | $903,000 | 3.21% |
RUDMAN ERROL M | 37,001 | $3,978,000 | 2.76% |
INDUS CAPITAL PARTNERS, LLC | 167,104 | $17,967,000 | 2.33% |
Ativo Capital Management LLC | 90,748 | $9,757,000 | 2.30% |
THOMAS WHITE INTERNATIONAL LTD | 130,130 | $13,991,000 | 2.08% |
OBERWEIS ASSET MANAGEMENT INC/ | 55,855 | $6,006,000 | 1.80% |
Cormorant Asset Management, LP | 112,867 | $12,135,000 | 1.64% |
BARING ASSET MANAGEMENT Ltd | 143,512 | $15,430,000 | 1.06% |